ScholarIQanswers from OpenAlex

Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease

PaperCitations, authors & open-access status

Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease have?

ScholarIQcitation count

Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease has 11 citations in the OpenAlex counts ScholarIQ stores.

When was Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease published?

ScholarIQyear

Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease has 2022 year in the ScholarIQ index.

What is the open-access status of Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease?

ScholarIQoa status

Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease has gold oa status in the ScholarIQ index.

What is the DOI of Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease?

ScholarIQdoi

The DOI for Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease is on the source record.

What is the PMID of Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease?

ScholarIQpmid

The PMID for Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease is on the source record.

What is the OpenAlex record for Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease?

ScholarIQopenalex

The OpenAlex for Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial